Quick Takeaways
- Keith Woods has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $27,816,037.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Keith Woods
- Location
- Boston, MA
- Summary
- The estimated net worth of Keith Woods is at least $27,816,037 dollars as of 24 Feb 2026. Keith Woods is the Chief Operating Officer of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $27.45M. Keith Woods is the Director of ROCKET PHARMACEUTICALS, INC. and owns shares of ROCKET PHARMACEUTICALS, INC. (RCKT) stock worth about $360.1K. Keith Woods is the Director of X4 Pharmaceuticals, Inc and owns shares of X4 Pharmaceuticals, Inc (XFOR) stock worth about $1.1K.
- Signature
- /s/ Donna M. Cochener, Attorney-in-Fact for Keith Woods
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Keith Woods and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Scholar Rock Holding Corp ($27,454,779).
- Past-year value change for that position: -$715,054.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Keith Woods
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | Chief Operating Officer | $27,454,779 | -$715,054 | -2.5% | 09 Feb 2026 |
| RCKT, RCKTW | ROCKET PHARMACEUTICALS, INC. | Director | $360,118 | 13 Jun 2024 | ||
| XFOR | X4 Pharmaceuticals, Inc | Director | $1,140 | 09 Jun 2025 | ||
| NGNE | Neurogene Inc. | Director | 20 Feb 2026 | |||
| TCRX | TScan Therapeutics, Inc. | Director | 30 Jun 2025 |
Insider Transactions Reported by Keith Woods:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.